Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,851
Closed -$1.08M 255
2024
Q1
$1.08M Sell
13,851
-43
-0.3% -$3.2K 0.11% 156
2023
Q4
$993K Sell
13,894
-89
-0.6% -$6.2K 0.11% 161
2023
Q3
$970K Sell
13,983
-8
-0.1% -$605 0.12% 152
2023
Q2
$1.13M Hold
13,991
0.13% 147
2023
Q1
$1.13M Sell
13,991
-752
-5% -$60.5K 0.15% 147
2022
Q4
$1.1M Buy
14,743
+6,706
+83% +$478K 0.15% 150
2022
Q3
$519K Hold
8,037
0.07% 200
2022
Q2
$557K Buy
8,037
+170
+2% +$12.6K 0.07% 206
2022
Q1
$604K Buy
7,867
+176
+2% +$12.7K 0.07% 215
2021
Q4
$589K Hold
7,691
0.06% 220
2021
Q3
$568K Hold
7,691
0.07% 215
2021
Q2
$513K Hold
7,691
0.06% 226
2021
Q1
$572K Hold
7,691
0.07% 214
2020
Q4
$560K Hold
7,691
0.08% 203
2020
Q3
$511K Sell
7,691
-247
-3% -$15.6K 0.08% 197
2020
Q2
$452K Hold
7,938
0.07% 205
2020
Q1
$279K Buy
7,938
+888
+13% +$42.3K 0.05% 233
2019
Q4
$368K Hold
7,050
0.07% 236
2019
Q3
$356K Hold
7,050
0.07% 232
2019
Q2
$339K Hold
7,050
0.07% 237
2019
Q1
$341K Buy
7,050
+19
+0.3% +$857 0.07% 237
2018
Q4
$289K Buy
+7,031
New +$288K 0.09% 192

Other funds holding HOLX

Kintegral Advisory's HOLX Position: Q2 2024 in Review

Kintegral Advisory sold out of Hologic (HOLX) in Q2 2024, closing a stake of 13,851 shares — an estimated $1.08M sold.

Kintegral Advisory first reported a position in HOLX in Q4 2018 and held it in 22 quarters. The position peaked at $1.13M in Q2 2023. 702 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

  • Kintegral Advisory reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
  • Kintegral Advisory sold 13,851 Hologic shares in Q2 2024, an estimated $1.08M.
  • Kintegral Advisory first reported a position in Hologic in Q4 2018 and held it in 22 quarters.
  • Kintegral Advisory's Hologic position peaked at $1.13M in Q2 2023.
  • 702 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on Kintegral Advisory's 13F filing for Q2 2024, filed 26 Jul 2024.